 Eidos Therapeutics Inc NASDAQ:EIDX has been given an average recommendation of Hold by the thirteen brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company. The average twelve-month target ... 